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ABSTRACT In the large majority of cases, HIV infection is established by a single
variant, and understanding the characteristics of successfully transmitted variants is
relevant to prevention strategies. Few studies have investigated the viral determi-
nants of mother-to-child transmission. To determine the impact of Gag-protease-
driven viral replication capacity on mother-to-child transmission, the replication ca-
pacities of 148 recombinant viruses encoding plasma-derived Gag-protease from 53
nontransmitter mothers, 48 transmitter mothers, and 47 infected infants were as-
sayed in an HIV-1-inducible green fluorescent protein reporter cell line. All study par-
ticipants were infected with HIV-1 subtype C. There was no significant difference in
replication capacities between the nontransmitter (n  53) and transmitter (n  44)
mothers (P  0.48). Infant-derived Gag-protease NL4-3 recombinant viruses (n  41)
were found to have a significantly lower Gag-protease-driven replication capacity
than that of viruses derived from the mothers (P  0.0001 by a paired t test). High
percent similarities to consensus subtype C Gag, p17, p24, and protease sequences
were also found in the infants (n  28) in comparison to their mothers (P  0.07,
P  0.002, P  0.03, and P  0.02, respectively, as determined by a paired t test).
These data suggest that of the viral quasispecies found in mothers, the HIV mother-
to-child transmission bottleneck favors the transmission of consensus-like viruses
with lower viral replication capacities.
IMPORTANCE Understanding the characteristics of successfully transmitted HIV vari-
ants has important implications for preventative interventions. Little is known about
the viral determinants of HIV mother-to-child transmission (MTCT). We addressed the
role of viral replication capacity driven by Gag, a major structural protein that is a
significant determinant of overall viral replicative ability and an important target of
the host immune response, in the MTCT bottleneck. This study advances our under-
standing of the genetic bottleneck in MTCT by revealing that viruses transmitted to
infants have a lower replicative ability as well as a higher similarity to the popula-
tion consensus (in this case HIV subtype C) than those of their mothers. Further-
more, the observation that “consensus-like” virus sequences correspond to lower in
vitro replication abilities yet appear to be preferentially transmitted suggests that vi-
ral characteristics favoring transmission are decoupled from those that enhance rep-
licative capacity.
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It is well known that 80 to 90% of heterosexual HIV-1 transmissions are established bya single viral variant due to a genetic bottleneck (1, 2). Understanding the charac-
teristics of successfully transmitted viral variants may aid in the development of HIV
prevention strategies. Overall, transmitted HIV-1 strains tend to display CCR5 corecep-
tor usage (3). Moreover, HIV-1 strains transmitted heterosexually tend to have shorter
envelope variable loops with fewer glycosylation sites (thereby making them more
neutralization sensitive [3, 4]) and tend to exhibit enhanced interferon alpha resistance
(5, 6) (although this may not be the case for all HIV-1 subtypes [7]). Heterosexual HIV-1
transmission also tends to select for transmitted viruses with greater genetic similarity
to the HIV-1 subtype consensus sequence (7, 8) but not an enhanced viral replicative
capacity (7). Importantly, the strength of the transmission bottleneck, and, thus, the
selection bias for certain viral characteristics, differs significantly by mode of transmis-
sion: the selection bias for consensus-like founder variants is more relaxed in the case
of male-to-female transmission than vice versa (8), and there are distinct genetic
footprints of the transmitted/founder virus that distinguish between heterosexual
versus men-who-have-sex-with-men (MSM) transmissions (9).
While a relatively large number of studies have investigated the role of host factors,
including HLA allele sharing, placental CCR5 expression, polymorphisms in chemokine
and other immunomodulatory genes, and maternal HIV-specific antibodies, in mother-
to-child transmission (MTCT) risk (10–16), relatively little is known regarding the role of
viral factors in MTCT. Kong and colleagues found that viral replication capacity deter-
mined by the V1-to-V5 region of Env was a determinant of MTCT from chronically
infected mothers to their infants; specifically, the faster-replicating variants were pref-
erentially transmitted (17). No studies have yet investigated the effect of Gag-driven
viral replication capacity on MTCT, although it has been found to be a significant
determinant of adult disease progression (18–20). Gag is an important structural
protein crucial for viral replication (21) and has been shown to contribute significantly
to whole-isolate replication capacity (22, 23), explaining as much as 72% of the
variability in HIV-1 replication capacity (24), although another recent study did not
observe this relationship (25). Furthermore, Gag has been shown to be an important
target of CD8 T cell (cytotoxic T lymphocyte [CTL]) immune responses (26, 27), and
CTL escape mutations in critical Gag epitopes have been shown to significantly reduce
viral replication capacity (28–32).
The purpose of this study was to investigate viral determinants of MTCT in HIV-1
subtype C, the most prevalent subtype globally. The specific aims were 2-fold: first to
determine whether the Gag-protease-driven replication capacity of viruses in mothers
is a determinant of transmission to their infants and second to determine whether
viruses that establish infection in infants have a different Gag-protease-driven replica-
tion capacity than that of viruses present in their mothers. We studied totals of 53
nontransmitter mothers, 48 transmitter mothers, and 41 mother-infant pairs (MIPs).
Gag-protease-driven replication capacity did not distinguish between transmitter and
nontransmitter mothers; however, the viruses that were successfully transmitted to the
infants displayed significantly lower replication capacities than those of viruses from
the mothers. Sequence analysis determined that the transmitted viruses were biased
toward the consensus sequence.
RESULTS
Transmitter mothers transmit viruses with lower replication capacity to their
infants. The MTCT bottleneck was characterized by comparing the viral replication
capacities of mothers and infants. The chronically HIV-1-infected mothers harbor a
diverse pool of viruses that consists of a heterogeneous mixture of variants. MTCT acts
as a bottleneck and allows very few variants to be transmitted to the infant (33). Indeed,
sequencing of Gag-protease from the transmitter mothers and their infants revealed
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that the mothers have more mixtures (median 10; interquartile range [IQR], 5 to 15.5)
than their infants (median 2; IQR, 0 to 4) (P 0.0003 as determined by a paired t test)
(data not shown). It was hypothesized that viral variants with a higher replication
capacity would be transmitted. The viral replication capacity driven by Gag-protease
was determined for 31 MIPs by constructing recombinant NL4-3 viruses encoding
patient-derived Gag-protease (using bulk PCR products) for the mothers and their
infants and then comparing the replication capacity of these viruses in a green
fluorescent protein (GFP) reporter T cell line. Contrary to our hypothesis, the viral
replication capacity of viruses infecting the infants (mean  0.62) was significantly
lower than that of viruses infecting the mothers (mean  0.76) (P  0.0001 as
determined by a paired t test) (Fig. 1A).
As this finding was unexpected, the experiments were repeated in an independent
laboratory on a subset of 19 MIPs and an additional 10 MIPs from the same cohort.
There was an excellent correlation between the replication capacity data on the same
19 MIPs that were generated in both laboratories (Pearson’s correlation [r]  0.83 and
P  0.0001) (data not shown), although the scales of these values differed between
laboratories, likely reflecting differences in the laboratory-adapted NL4-3 reference
stock used for normalization purposes. The repeated subset of 19 MIPs yielded the
same observation that viruses transmitted to the infants had lower replication capac-
ities (mean  0.76) than those of viruses from their mothers (mean  0.86) (P  0.03
as determined by a paired t test) (data not shown). When the additional 10 MIPs were
included in the original analysis of the 31 MIPs (n 41), the replication capacities of the
infants (mean  0.7) still remained significantly lower than those of their mothers
(mean  0.81) (P  0.0001 as determined by a paired t test) (Fig. 1B).
Next, we wished to investigate whether the mode of transmission may influence the
difference in viral replication capacities between the mothers and their infants. This was
investigated in the 41 MIPs. We hypothesized that in utero (IU) transmission may
present a greater bottleneck than intrapartum (IP) transmission. Therefore, we per-
formed the same comparison of viral replication capacities between mothers and
infants in MIPs classified as either IU or IP transmission. A significant difference in viral
replication capacities between mothers and their infants was observed in both trans-
mission groups (P  0.0012 [IU] and P  0.043 [IP] as determined by a paired t test)
(data not shown). The mean differences in replication capacities between viruses
derived from mothers and those derived their infants were similar in both the IU and
IP transmission groups (0.11 versus 0.1, respectively), indicating no evidence for a
greater bottleneck in IU versus IP transmission in terms of viral replication capacity.
No difference in viral replication capacities were observed between transmit-
ter and nontransmitter mothers. Although we observed that viruses with lower
FIG 1 Gag-protease-mediated viral replication capacities in HIV-infected mother-infant pairs. (A) Data from
31 mother-infant pairs (MIPs). (B) Data from the 31 MIPs in panel A and an additional 10 MIPs for which
analyses were undertaken in a separate laboratory. Gag-protease NL4-3 recombinant viruses derived from
the infants had significantly lower viral replication capacities than those of viruses their mothers (P 0.0001
as determined by a paired t test). Replication capacity was assayed in GXR cells by using flow cytometry and
normalized to the growth of the wild-type NL4-3 virus (replication capacity value of 1).
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replication capacities were selected for transmission, we wanted to investigate whether
viral replication capacity in the mother was a factor determining transmission, with the
initial hypothesis that a higher viral replication capacity in the mother would likely favor
transmission. Therefore, we compared viral replication capacities in 44 transmitter
mothers and 53 nontransmitter mothers who were matched for CD4 counts and viral
loads. No significant difference in viral replication capacities between transmitter
(mean  0.76) and nontransmitter (mean  0.74) mothers was found (P  0.48 as
determined by a t test) (Fig. 2). This suggests that Gag-protease-driven replication
capacity does not determine whether mothers transmit the virus to their infants.
Selection of consensus viruses for MTCT. The sequencing of Gag-protease from
bulk PCR products was successful for 28 out of the 31 MIPs for which replication
capacities were determined. Sequences were analyzed to investigate genetic determi-
nants of the differences in viral replication capacities between mothers and their
infants. The phylogenetic relatedness within each MIP was confirmed (Fig. 3). Gag-
protease from a subset of recombinant viruses was also sequenced; in all cases, these
sequences clustered with their respective bulk PCR sequences, as expected (data not
shown).
Previous studies of Gag-protease recombinant viruses and infectious molecular
clones found an inverse relationship between sequence similarity to the consensus and
in vitro replication capacity (7, 18). Furthermore, it was demonstrated that there is a
transmission bias for sequences that are consensus-like, using Gag, Pol, and Nef
sequencing of 137 adult subtype C-infected transmission pairs (8), and this finding was
corroborated in a whole-genome analysis of 6 transmission pairs from the same cohort
(7). Therefore, we analyzed the relationship between similarity to the consensus
sequence and replication capacity in our cohort and investigated whether similarities to
the consensus were significantly different between mothers and their infants. We found
an inverse relationship between the percent amino acid similarity of Gag, and each of
the individual Gag proteins, to the consensus sequence and viral replication capacity,
although this was statistically significant for only Gag p17 (r  0.41 and P  0.0003)
(data not shown). This was found to be in line with data from other studies (18). The
differences in Gag-protease percent amino acid similarities to the consensus between
sequences derived from mothers and those derived from infants were then compared.
There was a trend that infants had higher percent amino acid similarities to the
consensus sequence than their mothers for Gag (P  0.07 as determined by a paired
t test) (Fig. 4A). The infants had significantly higher percent amino acid similarity to the
consensus than their mothers for p17 (P  0.002) (Fig. 4B), p24 (P  0.03) (Fig. 4C), and
protease (P  0.02) (Fig. 4D).
However, this analysis does not account for the higher quantity of mixtures found
in the mothers than in the infants. To further evaluate whether there was a bias for the
transmission of consensus-like viruses while controlling for mixtures, per-site empirical
transmission frequencies were estimated as a function of site-specific amino acid
frequencies of circulating viruses, as previously described (8). A significant relationship
FIG 2 Gag-protease-mediated viral replication capacities in transmitter and nontransmitter mothers.
There is no significant difference in Gag-protease-mediated replication capacities between viruses
derived from mothers that transmit the virus to their infants and those derived from mothers that do not
transmit the virus to their infants (t test).
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(P  1e10) between amino acid frequency and transmission probability was ob-
served, both at sites where a mixture of amino acids was observed in the mother (Fig.
5A) and at sites where a single residue was observed (Fig. 5B), indicating that consensus
amino acids were more frequently transmitted. These results are consistent with the
circulating amino acid frequency as a correlate of transmission fitness.
Therefore, using two independent approaches, we observed that Gag-protease from
infant-derived viruses was more consensus-like than viruses derived from the mothers.
Although these results appear to contrast with lower in vitro replicative capacities
among infants, they are consistent with data from previous reports of an inverse
FIG 3 Viral phylogenetic relatedness between mother and child. Replication capacities were successfully determined for 41 MIPs, including 31 MIPs in the
Durban laboratory and an additional 10 MIPs from an independent laboratory. Out of the 41 pairs, sequencing data were successful for 39 pairs. A maximum
likelihood phylogenetic tree was constructed by using gag sequences, generated by Sanger and ultradeep sequencing, from 39 mother-infant pairs and the
subtype C reference sequence. Sequences from the mothers are highlighted in red, and sequences from the infants are highlighted in blue. Viral sequences
from the mothers and infants in each of the pairs clustered together, confirming the phylogenetic relatedness between viruses isolated from the mother and
infant in each pair.
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correlation between similarity to the consensus and in vitro replicative capacity (18),
which were corroborated here.
Early escape in infants does not explain lower viral replication capacity. CTL
escape mutations in critical Gag epitopes, particularly those at conserved residues, have
been shown to significantly reduce viral replication capacity (18, 28–32). Furthermore,
a significant negative correlation between Gag-protease-driven replication capacity
and the number of Gag epitope mutations was observed, when considering 20 CTL
escape mutations within defined Gag CTL epitopes (Table 1) (34). We first considered
whether the numbers of these known Gag epitope mutations differed significantly
between paired mother and infant sequences, irrespective of the HLA profile of the
participants. In 17 MIPs, the numbers of these mutations were identical in the mother
and infant sequences, but in the remaining 11 pairs, the sequences from the infants had
one or two fewer mutations than the sequences from their mothers (P  0.001 as
determined by a Wilcoxon matched-pairs signed-rank test) (Fig. 6). Furthermore, for the
17 MIPs with the same number of Gag epitope mutations, infants were still infected
with the virus with a lower replication capacity than that of viruses from their mothers
(P  0.0003 as determined by a paired t test). Therefore, the number of Gag mutations
in defined epitopes does not account for the lower replication capacity of viruses
transmitted to the infants. We extended our analysis of escape to include all HLA-
associated footprints in Gag identified previously (8) to further investigate whether
there is evidence of early escape in the infants that may be contributing to the lower
replication capacity of their viruses. However, only two infant-derived viruses contained
footprints (two in total), which corresponded to an HLA type expressed in the infant but
not in the mother.
FIG 4 Differences in percent similarities to the consensus subtype C sequence between Gag-protease sequences
derived from mothers and those derived from infants. Sequences derived from infants had higher percent amino
acid similarities to the consensus than did those derived from their mothers, for the Gag (A), Gag p17 (B), Gag p24
(C), and protease (D) regions (paired t test).
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Single-amino-acid variants do not explain replication capacity differences
between mothers and their infants.We performed an exploratory analysis to identify
amino acids in Gag and protease that have an impact on replication capacity in order
to then investigate whether these amino acids might differ between mothers and their
infants and explain differences in replication capacities. To do this, we used a data set
derived from 37 infants and 39 mothers (which included 28 MIPs, 9 unpaired infants,
FIG 5 Relationship between amino acid frequency of circulating viruses and mother-to-child transmission. The odds that the mother’s amino acid will be
transmitted to the infant is a function of the empirical frequency of amino acids among circulating viruses. Each plot shows the empirical transmission
probability (odds on a log10 scale) of a variant as a function of the frequency of the variant among 929 consensus Gag sequences isolated from chronically
infected, antiretroviral-naive patients from Durban, South Africa. Empirical transmission probabilities (solid colored lines) are estimated by counting the
proportion transmitted within a continuous sliding window with a 1-log-odds width with respect to the value on the abscissa. All log-odds values are smoothed
by adding a pseudocount equal to 1% of the number of Durban sequences used to estimate the cohort frequency. Gray lines represent a linear fit to the
sliding-window averages; shaded areas represent 95% confidence intervals estimated by using the percentile-t method on 1,000 multilevel bootstraps. Sites
in which a mixture was observed in the infant founder virus were excluded. (A) Among 13,441 nonmixture sites from 29 mothers, the odds of transmission is
associated with the frequency of the amino acid (AA) in the Durban cohort. (B) Among 281 sites containing two-amino-acid mixtures from 26 mothers, the
probability of transmission is associated with the relative cohort frequency of the amino acid. Transmission probability is calculated with respect to a randomly
chosen member of the mixture; the abscissa represents the relative frequency of that amino acid in the Durban cohort compared to the other amino acid in
the mixture. For both plots, the slope is significantly greater than 0 (P 2e10, as estimated by a multilevel logistic regression model [see Materials and
Methods]).
TABLE 1 List of Gag epitope mutations in defined Gag CTL epitopesa





















aThe underlined amino acids represent the consensus sequences in HIV-1 subtype C, with corresponding
escape variants shown in column 3.
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and 11 unpaired mothers) for whom Gag-protease sequencing and viral replication
capacity measurements had been successful. Using this data set, 30 amino acids in Gag
associated with decreased or increased replication capacity were identified, 5 of which,
7V, 7I, 28H, 62T, and 90K, were significant after correction for multiple comparisons (P
0.05 as determined by a Mann-Whitney U test; q  0.2) (Table 2). We then sought to
determine whether the frequencies of these 5 amino acids differed significantly be-
tween mothers and infants, using all available sequences (39 infants and 42 mothers),
and found that they did not. However, there was a trend that a higher proportion of
mothers were infected with viruses that had glutamine (Q) at position 28 of p17 (P 
0.05). This residue was one of 30 residues originally found to be associated with
increased replication capacity (P  0.04; q  0.62), although it was not among the 5
that remained significant after correction for multiple comparisons. We speculate that
H28Q potentially partially contributes to the higher replication capacity of viruses from
the transmitter mothers; however, overall, we did not convincingly find evidence of
single-amino-acid variants that consistently contribute to differences in replication
capacities between mothers and their infants.
DISCUSSION
While much progress has recently been made in characterizing the viruses that
establish infection following adult HIV-1 transmission (7–9), little is known about the
viral factors involved in MTCT. It has been reported that viruses transmitted to infants
have a higher Env-driven replication capacity than do viruses infecting their mothers
(17); however, the effect of other genes that contribute significantly to the overall
whole-isolate viral replication capacity, such as Gag (24), on MTCT remains unknown.
FIG 6 Differences in the numbers of Gag mutations between Gag sequences derived from mothers and those derived from
infants. CD8 T cell escape mutations in defined Gag epitopes (30) in mother-infant pairs were enumerated. In 17 MIPs,
the numbers of mutations were identical in the mother and infant sequences, but in the remaining 11 pairs, the infants
had one or two fewer mutations than the sequences from the mothers (P  0.001 as determined by a Wilcoxon
matched-pairs signed-rank test).
TABLE 2 Proportions of infants and mothers harboring amino acid residues in Gag significantly associated with altered replication






























Gag p17 Positive 7 V I 0.00008 0.01572 11/46 12/45 0.81
Gag p17 Negative 7 I I 0.00008 0.01572 34/46 32/45 0.82
Gag p17 Negative 28 H H 0.00209 0.164274 21/46 20/45 1
Gag p17 Positive 62 T K 0.00101 0.13231 5/46 6/45 0.76
Gag p17 Positive 90 K E 0.00175 0.164274 11/46 13/45 0.64
Gag p17 Positive 28 Q H 0.04306 0.623167 3/46 9/45 0.07
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Here we investigated the role of Gag-protease-driven replication capacity in MTCT in
HIV-1 subtype C infection.
Although samples from the infants were obtained 6 to 8 weeks after birth, previous
literature described viral populations in HIV-infected infants to be genetically homo-
geneous (35) and with low sequence-based diversity 6 to 8 weeks after birth (36).
Gounder and colleagues also found low intrapatient diversity during acute infection in
the case of HIV-infected adults, which had increased at 1 year postinfection (37).
Goonetilleke and colleagues analyzed the evolution of transmitted viruses in 3 adult
patients from the time of infection (38). The earliest escape that they detected in Gag
was at 45 days postinfection, which is after 6 weeks of infection. Therefore, we can
conclude that the virus in the infants at the time of sampling would be similar to the
transmitted virus.
We observed that while the Gag-protease-driven replication capacity in the mothers
was not a determinant of MTCT, there was selection for the transmission of viruses with
a lower Gag-protease-driven replication capacity to the infants. This finding is in
contrast to data from a previous study showing higher Env-driven replication capacities
in viruses transmitted to infants than that of viruses in the mothers for 7 MIPs (17),
suggesting that the selective forces associated with the transmission bottleneck may
differ between Gag and Env. While this finding contradicted our initial hypothesis that
transmitter mothers would transmit viruses with higher Gag-protease-driven replica-
tion capacities to their infants, it is in line with data from previous reports. Declines in
the replicative fitness of RNA viruses following passage across a transmission bottle-
neck (vertical transmission in particular) were described previously in the literature
(39–41); moreover, Adland et al. recently reported a trend toward lower HIV-1 Gag-
protease-driven replication capacities in infants than in their mothers for 43 MIPs
(although the infant-derived viruses studied were sampled months to years after
infection in that study) (34). Furthermore, a study of HIV-1 infectious molecular clones
from six adult heterosexual transmission pairs reported no selection for the transmis-
sion of viruses with higher replication capacities in peripheral blood mononuclear cells
(PBMCs) (7).
We compared the virus sequences from the mothers and those from their infants in
order to investigate the genetic determinants of the lower Gag-protease-driven repli-
cation capacity in the infants. Since CTL escape mutations in key Gag epitopes have
been linked to lower viral replication capacity (7, 8, 18, 28–32, 40), the numbers of these
mutations in paired mother-infant sequences were compared. It was observed that Gag
epitope escape mutations were frequently transmitted, as has been reported in studies
of viruses from early HIV-1 infection in adults (8, 19, 37), but overall, infant-derived
viruses had fewer Gag epitope escape mutations than did viruses from the mothers,
and therefore, the frequency of these mutations did not explain the difference in
replication capacities between mothers and their infants. We also investigated the
hypothesis that early escape in the infant-derived viruses was driving the lower
replication capacity by analyzing sequences for HLA-associated footprints in Gag, but
we found no evidence that this was the case.
Since previous studies of heterosexual transmission have identified a selection bias
for the transmission of consensus-like viruses (7, 8), we compared the percent amino
acid similarities to the consensus of the viruses derived from infants and their mothers
and also modeled the odds of MTCT based on the amino acid frequency of viruses
circulating in southern Africa. Our study is the first to show that viruses transmitted to
infants are significantly more similar to the subtype consensus than are those from their
mothers and that there is a bias for the transmission of consensus-like viruses from
mothers to their infants.
Consistent with our finding of lower Gag-protease-driven replication capacities in
the infant-derived viruses, our group and others previously showed that Gag-protease
NL4-3 recombinant viruses and Gag-MJ4 recombinant viruses that have a higher
percent similarity to the consensus Gag sequence have a lower replication capacity, and
this was most pronounced for the Gag p17 region in analyses of Gag-protease NL4-3
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recombinant viruses (18, 20). Using a much smaller sample size, we also find a
significant inverse relationship between the percent similarity to the consensus Gag
p17 sequence and replication capacity, which is consistent with data from those
previous studies. Furthermore, a recent study of infectious molecular clones found an
inverse relationship between similarity to the consensus sequence across the whole
genome and replication capacity in PBMCs (7). Taken together with data from those
previous studies, these findings suggest that viruses that are more consensus-like have
a lower intrinsic replication capacity (although they are likely more fit in the host in
the face of immune pressure, as they reflect the version of the virus best adapted to the
population [42]) and that these viruses are favored in both heterosexual transmission
and MTCT; i.e., they have a higher transmission fitness.
Two alternative interpretations merit mention. First, it is possible that parts of the
virus other than Gag, for example, Env, play a greater role in transmission. Indeed, the
in vitro Env-driven replication capacity was greater in infant-derived viruses then in
those from the mothers in 7 MIPs (17), although it should be noted that the majority
of infants in that study were likely infected via breastfeeding. The mode of transmission
may alter the selection bias and could possibly explain the different findings of Kong
et al. (17) showing that viruses with a higher Env-driven replication capacity were
favored in transmission. Since Claiborne et al. (24) showed a strong correlation (r2 
0.72 and P  0.03) between the replication capacities of infectious molecular clones
and Gag recombinant viruses from the same individuals, and it has been demonstrated
that viruses with a lower replication capacity are more consensus-like and are also
favored in heterosexual transmission (7), it seems more probable that the viruses
transmitted to infants in the present study had a lower overall in vitro replication
capacity, although genes other than Gag also make a significant contribution to the
overall replication capacity (43, 44). A second possibility is that viral replication capacity
is not intrinsic but rather cell type dependent; it is conceivable, for example, that a
given viral variant could exhibit a low replication ability in peripheral cells but a high
replication ability in mucosal cells infected during transmission, as a consequence of
the differential expression of specific host factors in these cell types (33, 34, 39–46, 50).
However, the viruses derived from infants who were infected in utero also exhibited
significantly lower replication capacities than those of viruses from their mothers,
arguing against this as an explanation for the study findings.
Finally, the observation that consensus-like virus sequences exhibit a lower in vitro
replication ability yet appear to be preferentially transmitted suggests that the viral
characteristics favoring transmission are largely decoupled from those that enhance
replicative capacity. Nevertheless, it is still possible that replicative (“intrinsic”) fitness
and transmission fitness are largely synonymous. In vitro replicative capacity and
sequence-based comparisons to circulating viruses may simply be noisy estimates that
measure different aspects of intrinsic fitness. This hypothesis is supported in principle
by the correlations between these measures and viral loads (18, 20), which are weak
enough to simultaneously permit positive correlations with viral loads yet negative
correlations between each other. Thus, intrinsic fitness may be only approximately
estimated by these two independent, and at times conflicting, measures, while there
would be a few sites in which transmission and intrinsic fitness are fundamentally
different. Our cautious interpretation of the identification of 28H within Gag p17 as a
consensus residue that has been linked with lower in vitro replicative capacity (19) and
yet may confer increased transmission fitness provides a possible example. Notably, this
site is in the region of p17 that has been implicated in binding the cytoplasmic tail of
gp41 and facilitating virion incorporation (51) and thus may suggest that selection in
Env is driving the selection of this site through an epistatic interaction. Conversely, an
epistatic interaction with Env may suggest an artifact in this in vitro system, which does
not use autologous Env proteins, and is thus an assay limitation.
The assay used in the present study is designed to capture the Gag-protease-driven
replication capacity of the quasispecies infecting an individual, and previously, this
measure was found to correlate significantly with the replication capacity of whole
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isolates derived from the same individuals (22). However, a potential limitation is that,
in the mothers, the variants in the quasispecies with the highest replication capacity
may grow out in culture (although it should be noted that about 60% of the mixtures
in the bulk PCR products are represented in the virus stocks obtained in this assay [18]).
If the variant in the infant is a random selection of the mother’s variants, it would be
expected that, across the cohort, the replication capacities of the infants’ viruses would
on average be lower than those of the viruses from the mothers. However, in this
scenario, it is unlikely that we would observe with such high consistency, in 29 out of
31 MIPs, that the viruses in the infants had lower replication capacities, as, by chance,
a greater proportion of the infant variants should have had a replication capacity at
least equal to that of the virus in the mother. Furthermore, in this scenario, if trans-
mission favored the variants with the highest replication capacities (our initial hypoth-
esis, disputed by the data here), in the majority of the MIPs, equal replication capacities
of the mother and infant variants would be observed. Finally, if the infant virus
represented the consensus of the maternal variants and there was selection in culture
for the most fit maternal variant, this may have driven the results observed here;
however, in 20% of cases where there were nucleotide mixtures in the maternal virus,
the dominant nucleotide in the mother was not transmitted to the infant, indicating
that the virus transmitted to the infant is not simply the consensus of the maternal
variants. Rather, while accounting for the higher number of mixtures in the maternal
sequences, we demonstrated here that there is a bias for the transmitted virus to be
closer to the consensus of the circulating population variants. Therefore, we conclude
that it is improbable that this assay limitation was responsible for our finding of
transmission of variants with low Gag-protease-driven replication capacities.
It is furthermore important to note the assay limitation of subtype mismatch between
the Gag-protease insert and the NL4-3 backbone. Nevertheless, in previous studies, the
assay yielded data that are clinically relevant (18, 52–54), and in a recent comparison of
Gag-protease-driven replication between different subtypes, the subtype-specific hierarchy
remained consistent regardless of whether a subtype C (pZM246-F10) or a subtype B
(NL4-3) backbone was used (22).
In conclusion, MTCT is characterized by a transmission bottleneck that favors the
transmission of viruses that have lower Gag-protease-driven replication capacities and
are closer to the circulating consensus from mother to infant out of their quasispecies
of the virus. While the consensus virus sequence corresponds to a lower in vitro
Gag-protease-driven replication ability, it favors virus transmission and thus reflects
increased transmission fitness. Further work is required to fully dissect intrinsic, trans-
mission, and posttransmission fitness.
MATERIALS AND METHODS
Study population. The study population was a pediatric cohort in Durban, South Africa, which was
described previously (55–57). Gag-protease-driven viral replication capacities were investigated in 53
HIV-1-positive nontransmitting mothers, 44 HIV-1-positive transmitting mothers, and 40 infants infected
with HIV-1 subtype C who were antiretroviral therapy naive except for a single dose of nevirapine, a
reverse transcriptase inhibitor (58). Studies have shown that tenofovir (also a reverse transcriptase
inhibitor) gel has no effect on Gag-protease-driven replication capacity (59), and therefore, it is unlikely
that single-dose nevirapine would impact Gag-protease-driven replication capacity. The nontransmitter
and transmitter mothers were matched for CD4 counts and viral loads. Plasma samples from the mothers
and infants were obtained at medians of 5 weeks (IQR, 3.8 to 6 weeks) before birth and 6 weeks (IQR, 4
to 8 weeks) after birth, respectively. Overall, there were 31 MIPs (Fig. 7). Replication capacities for 19 of
these 31 MIPs were also determined in an independent laboratory, along with an additional 10 MIPs from
the same cohort that were available to that laboratory but not available to the first laboratory. Of the 41
MIPs, 28 were IU transmission cases, defined as infants that seroconverted within 48 h after birth, and 13
were IP transmission cases (Fig. 7), defined as infants that seroconverted more than 48 h after birth.
Demographic and clinical data for all mothers and infants are shown in Tables 3 and 4, respectively.
Generation of Gag-protease NL4-3 recombinant viruses. Gag-protease NL4-3 recombinant viruses
were generated according to methods described previously (18). Briefly, gag-protease was amplified from
viral RNA extracted from plasma by performing nested PCR using the primers and conditions described
previously (18). The pNL4-3Δgag-protease plasmid was generated (52) and prepared (18) as described
previously. Ten micrograms of BstEII-digested pNL4-3Δgag-protease and 80 l of the gag-protease PCR
product were cotransfected into 2.5 million CEM-GXR25 cells (GXR cells) (60) in 800 l R10 medium via
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electroporation at 300 V and 500 F (18, 37). The electroporated cells were allowed to recover for 1 h
before the contents of each cuvette were transferred to 25-cm2 flasks containing 4 ml medium. Five
milliliters of medium was added to each of the flasks after 5 days. Flow cytometry of the transfected cells
was performed from day 12 onwards to measure the percentage of cells infected by recombinant viruses.
Culture supernatants were harvested once the cells were 25 to 30% infected and were stored in 0.5- to
1-ml aliquots at 80°C for use in subsequent titration and replication assays.
Titration and replication capacity assays of Gag-protease recombinant viruses. Titration and
replication capacity assays were performed as described previously (45, 46, 52). GXR cells were infected
at a multiplicity of infection (MOI) of 0.003. The replication capacity of the recombinant viruses
determined by Gag-protease function is indicated by the mean slope of exponential growth from days
3 to 6, which was determined by using the semilog method in Excel. These values were normalized to
the values for the positive control, wild-type NL4-3, which was included in each assay. The replication
capacity assays were done in duplicate. If the difference in the replication capacities of a sample between
the two assays exceeded 0.1, a third replication assay was done for those samples. The final replication
capacity for each sample was calculated as an average of the replication capacities determined by all
assays done for that sample.
Gag-protease sequencing and phylogenetic analysis. The gag-protease gene was sequenced as
described previously (18). The gag-protease PCR product was diluted 1:15 in diethyl pyrocarbonate-
treated water and sequenced by using a BigDye Terminator v3.1 cycle sequencing kit (Applied Biosys-
tems, Foster City, CA) (47), using primers described previously (18) in addition to the following primers:
5=-TGACTAGCGGAGGCTAGAA-3= (corresponding to HIV-1 subtype B genomic reference strain HXB2
nucleotides 763 to 781), 5=-AGAGAACCAAGGGGAAGTGA-3= (nucleotides 1474 to 1493), 5=-ACAGGCTAA
TTTTTTAGGGA-3= (nucleotides 2076 to 2095), 5=-CTAATACTGTATCATCTGCTCCTGT-3= (nucleotides 2353
to 2328), 5=-TCCAATTCCTCCTATCATTTTTGG-3= (nucleotides 2405 to 2382), and 5=-TCTTCTGTCAATGGCC
ATTG-3= (nucleotides 2635 to 2616). Sequences were run on the ABI 3130xl genetic analyzer (Applied
Biosystems) and edited in Sequencher (Gene Codes) (47). The REGA HIV subtyping tool was used to
confirm that all sequences were subtype C gag-protease sequences (http://bioafrica.mrc.ac.za/). Nucle-
otides for each gene were aligned manually in Se-Al v.2.0a11. Maximum likelihood phylogenetic trees
were generated by using PhyML (http://www.hiv.lanl.gov/) and visualized by using Figtree v.1.2.2
(http://tree.bio.ed.ac.uk/software/figtee/). For the calculation of similarity to the consensus, sequences
were aligned to the HXB2 sequence by using Gene cutter (http://www.hiv.lanl.gov/content/sequence/
GENE_CUTTER/cutter.html), and insertions relative to HXB2 were removed by using BioEdit 7.0. The









Median CD4 T cell count (cells/mm3) (IQR) 325 (188–443) 289 (147–422) 0.32
Median viral load (log10 copies/ml) (IQR) 5 (4.4–5.4) 4.7 (3.9–5.3) 0.23
FIG 7 Study population. Plasma samples were obtained for 44 transmitter mothers and 40 infants. Gag-protease was successfully sequenced
for 29 MIPs, and Gag-protease-driven replication capacities were successfully determined for 31 MIPs. However, altogether, replication capacity
assays and sequencing were successful for 28 MIPs. Altogether, Gag-protease-driven replication capacities were determined for 41 MIPs (31 from
the Durban laboratory and 10 from an independent laboratory). The mode of transmission within 28 out of the 41 MIPs was in utero
mother-to-child transmission (MTCT). The mode of transmission for the remaining 13 MIPs was intrapartum transmission.
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percent amino acid similarities of Gag and protease to the most recent (2004) consensus subtype C
sequence were calculated by using the sequence identity matrix function in BioEdit 7.0.
Modeling the odds of transmission based on amino acid frequency in southern African chronic
sequences. Per-site empirical transmission frequencies were estimated as a function of site-specific
amino acid frequencies of circulating viruses as described previously (8). Briefly, for 28 matched
mother-child pairs (for whom gag-protease sequencing was successful), mother and child bulk gag amino
acid sequences were aligned to a reference panel of circulating Durban gag sequences (8). We then
identified each codon in the mother’s bulk gag sequence where the dominant amino acid was also
present in the child (sites in which an amino acid mixture was observed in the child, or a mixture of more
than two amino acids was observed in the mother, were excluded). The frequency of each amino acid
at the corresponding site in the Durban alignment was then used as a reference; frequencies were
smoothed with a 1% “pseudocount.” To visualize the probability of transmission as a function of the
frequency of a variant in the Durban cohort, we used a sliding-window approach in which we measured
the observed proportion of sites that were transmitted within a given window. We used a window size
of 1 on the log-odds scale and included only windows with at least 20 observations. To estimate 95%
confidence intervals for the empirical transmission probability curves, we used a block bootstrap
approach using the percentile-t method (48). For each of 1,000 bootstrap replicates, we sampled, with
replacement, the mother-child pairs and then the sites within each sampled pair. We then estimated the
empirical transmission probability for each cohort frequency value observed in the complete data set.
The percentile-t 95% confidence interval was then estimated independently for each cohort frequency
value. To estimate P values, we used a multilevel logistic regression model, in which the dependent
variable is whether the site was transmitted and the fixed effect is the (smoothed) log odds of the
frequency of the variant in the Durban cohort (or of the relative frequency in the case of the 2-amino-acid
mixtures). Random offsets were estimated for each protein within Gag (p17, p24, and p15) and for each
mother-child pair. We report the P value for the null hypothesis that the fixed effect was equal to 0.
Statistical analysis. The Gag-protease-driven replication capacities of viruses infecting transmitting
mothers and their infants were compared by performing the paired t test for MIPs, and the Student t test
was used when transmitter and nontransmitter mothers were compared. The percent amino acid
similarities of Gag, Gag p17, Gag p24, and protease to the consensus C sequence were compared
between transmitter mothers and their infants within MIPs by using the paired t test. The relationship
between the cohort frequency of amino acids and transmission was assessed by using a multilevel
logistic regression model to determine significance, as described in detail above. Gag-protease se-
quences from mothers and infants were analyzed by using the Mann-Whitney U test to identify specific
single codons in Gag-protease where amino acid variants occurring at a frequency of5 were associated
with increased or decreased replication capacity. q values were determined to account for multiple
comparisons (49). Associations were considered to be significant if the P value was0.05 and the q value
was 0.2. Two-tailed Fisher’s exact test was done to determine if the proportions of replication
capacity-associated residues in the mothers and infants were significantly different.
Ethical considerations. This study is a subset of a larger study, which is entitled “Augmentation of
HIV-specific T cell immunity by highly active antiretroviral therapy (HAART) instituted in acute paediatric
HIV infection followed by supervised treatment interruptions (STI)” (http://hpp.ukzn.ac.za/Cohorts.aspx).
Full ethical approval, from the Biomedical Research Ethics Committee of the Nelson R. Mandela School
of Medicine, University of KwaZulu-Natal (reference no. E065/01), and informed patient consent were
obtained for this study.
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